Literature DB >> 19696976

Transmissible spongiform encephalopathies with P102L mutation of PRNP manifesting different phenotypes: clinical, neuroimaging, and electrophysiological studies in Chinese kindred in Taiwan.

Nai-Fang Chi1, Yi-Chung Lee, Yi-Chun Lu, Hsiu-Mei Wu, Bing-Wen Soong.   

Abstract

A P102L point mutation in the prion protein gene (PRNP) usually causes Gerstmann-Sträussler-Scheinker disease (GSS), which is a rare hereditary transmissible spongiform encephalopathy (TSE). The clinical features include ataxia in 50s age group with subsequent dementia, spastic paraparesis and extrapyramidal signs. Many families have been reported from the Caucasian population, but only one from the Chinese. We hereby report a large Chinese family with P102L mutation of PRNP whose clinical manifestations at onset were intriguingly heterogeneous, either rapidly progressive dementia with scanty other neurological features or slowly progressive ataxia followed by cognitive impairment. The four-generation pedigree included eight patients with a mean age at onset of 36.9 +/- 12.9 (mean +/- SD) years. Mean disease duration to death in the four patients was 5.5 +/- 1.7 (mean +/- SD) years. Molecular analysis revealed a P102L mutation and M129 polymorphism in the PRNP gene in all affected individuals. TSE with P102L mutation of PRNP appears to have a remarkably variable phenotypic expressivity that may change with time and does not appear related to the codon 129 polymorphism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19696976     DOI: 10.1007/s00415-009-5290-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  42 in total

Review 1.  Neuropathology of prion diseases.

Authors:  Herbert Budka
Journal:  Br Med Bull       Date:  2003       Impact factor: 4.291

Review 2.  Prion diseases.

Authors:  J Collinge; M S Palmer
Journal:  Curr Opin Genet Dev       Date:  1992-06       Impact factor: 5.578

3.  Cutoff scores of the cognitive abilities screening instrument, Chinese version in screening of dementia.

Authors:  Ker-Neng Lin; Pei-Ning Wang; Chia-Yih Liu; Wei-Ta Chen; Yi-Chung Lee; Hsiu-Chih Liu
Journal:  Dement Geriatr Cogn Disord       Date:  2002       Impact factor: 2.959

4.  Genetic prion disease: the EUROCJD experience.

Authors:  Gábor G Kovács; Maria Puopolo; Anna Ladogana; Maurizio Pocchiari; Herbert Budka; Cornelia van Duijn; Steven J Collins; Alison Boyd; Antonio Giulivi; Mike Coulthart; Nicole Delasnerie-Laupretre; Jean Philippe Brandel; Inga Zerr; Hans A Kretzschmar; Jesus de Pedro-Cuesta; Miguel Calero-Lara; Markus Glatzel; Adriano Aguzzi; Matthew Bishop; Richard Knight; Girma Belay; Robert Will; Eva Mitrova
Journal:  Hum Genet       Date:  2005-11-15       Impact factor: 4.132

5.  Novel twelve-generation kindred of fatal familial insomnia from germany representing the entire spectrum of disease expression.

Authors:  A Harder; K Jendroska; F Kreuz; T Wirth; C Schafranka; N Karnatz; A Théallier-Janko; J Dreier; K Lohan; D Emmerich; J Cervós-Navarro; O Windl; H A Kretzschmar; P Nürnberg; R Witkowski
Journal:  Am J Med Genet       Date:  1999-12-03

6.  A new variant of prion disease.

Authors:  J Collinge; M Rossor
Journal:  Lancet       Date:  1996-04-06       Impact factor: 79.321

7.  Source localization of periodic sharp wave complexes using independent component analysis in sporadic Creutzfeldt-Jakob disease.

Authors:  Ki-Young Jung; Dae-Won Seo; Duk L Na; Chin-Sang Chung; Il Keun Lee; Kyungmi Oh; Chang-Hwan Im; Hyun-Kyo Jung
Journal:  Brain Res       Date:  2007-02-07       Impact factor: 3.252

Review 8.  Prion diseases of humans and animals: their causes and molecular basis.

Authors:  J Collinge
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

Review 9.  Transmissible spongiform encephalopathies.

Authors:  Steven J Collins; Victoria A Lawson; Colin L Masters
Journal:  Lancet       Date:  2004-01-03       Impact factor: 79.321

10.  Inherited prion disease with an alanine to valine mutation at codon 117 in the prion protein gene.

Authors:  G R Mallucci; T A Campbell; A Dickinson; J Beck; M Holt; G Plant; K W de Pauw; R N Hakin; C E Clarke; S Howell; G A Davies-Jones; M Lawden; C M Smith; P Ince; J W Ironside; L R Bridges; A Dean; I Weeks; J Collinge
Journal:  Brain       Date:  1999-10       Impact factor: 13.501

View more
  5 in total

1.  Incidence of and Mortality Due to Human Prion Diseases in Taiwan: A Prospective 20-Year Nationwide Surveillance Study from 1998 to 2017.

Authors:  Chih-Ching Liu; Ling-Yun Fan; Yu Sun; Chung-Te Huang; Ta-Fu Chen; Chien-Jung Lu; Wan-Yuo Guo; Yang-Chyuan Chang; Ming-Jang Chiu
Journal:  Clin Epidemiol       Date:  2020-10-14       Impact factor: 4.790

2.  Tau Protein Phosphorylated at Threonine-231 is Expressed Abundantly in the Cerebellum in Prion Encephalopathies.

Authors:  Vıctor Manuel Gómez-López; Amparo Viramontes-Pintos; Miguel Ángel Ontiveros-Torres; Linda Garcés-Ramírez; Fidel de la Cruz; Ignacio Villanueva-Fierro; Marely Bravo-Muñoz; Charles R Harrington; Sandra Martínez-Robles; Petra Yescas; Parménides Guadarrama-Ortíz; Mario Hernandes-Alejandro; Francisco Montiel-Sosa; Mar Pacheco-Herrero; José Luna-Muñoz
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

3.  A family with hereditary cerebellar ataxia finally confirmed as Gerstmann-Straussler-Scheinker syndrome with P102L mutation in PRNP gene.

Authors:  Ling Long; Xiaodong Cai; Yaqing Shu; Zhengqi Lu
Journal:  Neurosciences (Riyadh)       Date:  2017-04       Impact factor: 0.906

4.  Novel prion mutation (p.Tyr225Cys) in a Korean patient with atypical Creutzfeldt-Jakob disease.

Authors:  Eva Bagyinszky; YoungSoon Yang; Vo Van Giau; Young Chul Youn; Seong Soo A An; SangYun Kim
Journal:  Clin Interv Aging       Date:  2019-08-02       Impact factor: 4.458

Review 5.  Characterization of mutations in PRNP (prion) gene and their possible roles in neurodegenerative diseases.

Authors:  Eva Bagyinszky; Vo Van Giau; Young Chul Youn; Seong Soo A An; SangYun Kim
Journal:  Neuropsychiatr Dis Treat       Date:  2018-08-14       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.